Found: 23
Select item for more details and to access through your institution.
Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, p. 1, doi. 10.1186/s13075-018-1556-5
- By:
- Publication type:
- Article
Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 2, p. 259, doi. 10.1002/acr.24442
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: Results from the Consortium of Rheumatology Researchers of North America registry.
- Published in:
- Arthritis Care & Research, 2011, v. 63, n. 6, p. 856, doi. 10.1002/acr.20452
- By:
- Publication type:
- Article
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time.
- Published in:
- Rheumatology, 2017, v. 56, n. 7, p. 1162, doi. 10.1093/rheumatology/kex081
- By:
- Publication type:
- Article
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.
- Published in:
- Rheumatology, 2016, v. 55, n. 1, p. 80, doi. 10.1093/rheumatology/kev267
- By:
- Publication type:
- Article
Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
- Published in:
- Rheumatology, 2015, v. 54, n. 7, p. 1210, doi. 10.1093/rheumatology/keu438
- By:
- Publication type:
- Article
Exposure–Response Analyses of Upadacitinib Efficacy and Safety in Phase II and III Studies to Support Benefit–Risk Assessment in Rheumatoid Arthritis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 994, doi. 10.1002/cpt.1671
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐Naive Patients With Moderately‐to‐Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Multicenter, Multi‐Country, Randomized, Double‐Blind, Active Comparator–Controlled Trial
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 10, p. 1607, doi. 10.1002/art.41384
- By:
- Publication type:
- Article
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1788, doi. 10.1002/art.41032
- By:
- Publication type:
- Article
Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 12, p. 2857, doi. 10.1002/art.39808
- By:
- Publication type:
- Article
A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 12, p. 2867, doi. 10.1002/art.39801
- By:
- Publication type:
- Article
Frequency of Axial Spondyloarthritis Diagnosis Among Patients Seen by US Rheumatologists for Evaluation of Chronic Back Pain.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 7, p. 1669, doi. 10.1002/art.39612
- By:
- Publication type:
- Article
Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 4, p. 914, doi. 10.1002/art.39008
- By:
- Publication type:
- Article
A3: Efficacy and Safety of Adalimumab in Pediatric Patients With Enthesitis Related Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S4, doi. 10.1002/art.38414
- By:
- Publication type:
- Article
Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, n. 3, p. 667, doi. 10.1002/art.38283
- By:
- Publication type:
- Article
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 3, p. 534, doi. 10.1080/14397595.2020.1847776
- By:
- Publication type:
- Article
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 2, p. 903, doi. 10.1007/s40744-021-00305-z
- By:
- Publication type:
- Article
Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE).
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-020-02387-6
- By:
- Publication type:
- Article
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 3, p. 444, doi. 10.1093/ecco-jcc/jjab161
- By:
- Publication type:
- Article
A PHASE 3, RANDOMIZED CONTROLLED TRIAL COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS.
- Published in:
- Acta Reumatológica Portuguesa, 2019, p. 27
- By:
- Publication type:
- Article